Ignite Creation Date:
2024-05-06 @ 6:32 PM
Last Modification Date:
2024-10-26 @ 2:50 PM
Study NCT ID:
NCT05698329
Status:
RECRUITING
Last Update Posted:
2024-02-05
First Post:
2023-01-16
Brief Title:
Effect of AIV007 by Periocular Administration in Subjects With nAMD or DME
Sponsor:
AiViva BioPharma Inc
Organization:
AiViva BioPharma Inc
Study Overview
Official Title:
A Phase 1 Study of the Safety Pharmacokinetics and Exploratory Efficacy of Periocular Administration of AIV007 in Subjects With Macular Edema Secondary to Neovascular Age-Related Macular Degeneration nAMD or Diabetic Macular Edema DME
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine safety pharmacokinetics and duration of effect of periocularly administered AIV007 gel suspension in subjects with neovascular age-related macular degeneration nAMD or diabetic macular edema DME
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None